VivoSeq
Other

Pain Perception

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Pain Perception is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

78/100

Attrition Rate

13/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed7 · 47%
Unknown status3 · 20%
Recruiting2 · 13%
Terminated2 · 13%
Active, not recruiting1 · 7%

Trial Activity

15 trials

Pain Perception: Lidocaine Rate/Temp/Buffer
Active, not recruiting·NNorthwestern University·N/A·NCT02823002·26 enrolled
Pain Perception During Chorionic Villus Sampling
Completed··Phase 1·NCT03140293·120 enrolled
Pain Perception During Vulvar Biopsy
Terminated··Phase 4·NCT03654417·37 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)